Cancer vaccines are having a moment. Late last week, the drug makers Merck and Cambridge-based Moderna announced that ...
A new narrative review finds that the primary site of injury in multiple evanescent white dot syndrome remains contested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results